Please check your internet connection and try again.
# Liquid Paraffin + Milk of Magnesia + Sodium Picosulfate
## Overview
This combination is a multimodal laxative preparation containing a lubricant (liquid paraffin), an osmotic agent (magnesium hydroxide/milk of magnesia), and a contact stimulant (sodium picosulfate). It is typically used for the treatment of severe or chronic constipation.
## Primary Indications
* Management of chronic constipation
* Bowel evacuation prior to medical procedures (depending on specific concentration/formulation)
* Treatment of constipation associated with hemorrhoids or anal fissures
## Adult Dosing
Standard dosing typically follows a range of 10 mL to 30 mL once daily, preferably at bedtime. Because this is a complex combination product, precise dosing must strictly follow the manufacturer's product insert, as concentrations (liquid mg/mL) vary significantly by brand. Do not exceed the maximum daily dose specified on the product label.
## Pediatric Dosing
**Caution:** This combination is generally not recommended for children under 12 years of age without direct specialist oversight. Use in pediatrics is limited due to the risk of electrolyte imbalances and aspiration pneumonia (associated with liquid paraffin). If clinically required, doses are often calculated based on age/weight, but local institutional protocols should be strictly followed.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Magnesium accumulation can occur in patients with chronic kidney disease (CKD), leading to hypermagnesemia.
* **Hepatic Impairment:** No standard adjustments, but monitor for symptoms of impaired bowel motility.
* **Geriatric:** Start with the lowest effective dose; baseline kidney function should be assessed before initiating.
## Contraindications
* Known hypersensitivity to any component.
* Bowel obstruction or pseudo-obstruction.
* Acute surgical abdominal conditions (e.g., appendicitis, diverticulitis).
* Severe inflammatory bowel disease (ulcerative colitis, Crohn's disease).
* Presence of nausea, vomiting, or undiagnosed abdominal pain.
* Patients with difficulty swallowing (risk of lipid pneumonia due to liquid paraffin aspiration).
## Adverse Effects
* **Gastrointestinal:** Abdominal cramping, diarrhea, flatulence, nausea.
* **Systemic:** Electrolyte disturbances (hypokalemia, hypermagnesemia).
* **Pulmonary:** Lipid pneumonia (rare, usually associated with aspiration of liquid paraffin).
* **Anal:** Anal leakage or pruritus ani.
## Key Drug Interactions
* **Absorption:** Liquid paraffin may impair the absorption of fat-soluble vitamins (A, D, E, K).
* **Medication Absorption:** Laxatives can decrease the absorption of concurrently administered oral medications by reducing transit time. Space doses by at least 2 hours.
* **Magnesium interactions:** Tetracyclines, fluoroquinolones, and bisphosphonates should be separated from this medication by at least 2–4 hours to avoid chelation/decreased absorption.
## Monitoring
* Monitor for signs of electrolyte imbalance (muscle weakness, palpitations).
* Assess stool frequency and consistency.
* Monitor renal function in elderly or long-term users.
* Discontinue use if rectal bleeding occurs or if bowel movements do not occur after use.
## Clinical Pearls
* **Aspiration Risk:** This product is contraindicated in patients with dysphagia or those prone to aspiration.
* **Hydration:** Ensure adequate oral fluid intake to allow the osmotic component (magnesium) to function effectively and prevent dehydration.
* **Dependency:** Long-term daily use of stimulant-containing laxatives should be discouraged to prevent "lazy bowel" syndrome.
* **Variation:** Because this is a fixed-dose combination, clinicians must verify the specific concentration of sodium picosulfate and magnesium, as these vary by manufacturer.
***
**Disclaimer:** This information is for educational purposes only and does not replace professional clinical judgment. Always verify the specific brand's dose, concentrations, and contraindications by consulting the official local product monograph or your hospital's formulary.
